Application Nr Approved Date Route Status External Links
ANDA202890 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Zolmitriptan Orally Disintegrating Tablets Are A Serotonin (5-Ht) 1b/1d Receptor Agonist (Triptan) Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults ( 1 ) Limitations Of Use: Use Only After A Clear Diagnosis Of Migraine Has Been Established ( 1 ) Not Indicated For The Prophylactic Therapy Of Migraine ( 1 ) Not Indicated For The Treatment Of Cluster Headache ( 1 ) Zolmitriptan Orally Disintegrating Tablets Are Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. Limitations Of Use Only Use Zolmitriptan If A Clear Diagnosis Of Migraine Has Been Established. If A Patient Has No Response To Zolmitriptan Treatment For The First Migraine Attack, Reconsider The Diagnosis Of Migraine Before Zolmitriptan Is Administered To Treat Any Subsequent Attacks. Zolmitriptan Orally Disintegrating Tablets Are Not Indicated For The Prevention Of Migraine Attacks. Safety And Effectiveness Of Zolmitriptan Have Not Been Established For Cluster Headache.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Zolmitriptan ZOLMITRIPTAN ZINC15515

Comments